November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Jan 5, 2024, 17:31

Summary of 10 new indications/approvals in Heme Malignancies by FDA Oncology in 2023 – Oncology Brothers

Quoting Oncology Brothers on X/Twitter:

Summary of 10 new indications/approvals in Heme Malignancies (excluding CART) by FDA Oncology in 2023:

1. Zanubrutinib

2. Pirtobrutinib

3. Polatuzumab

4. Epcortimab

5. Glofitamab

6. Quizartinib

7. Talquetamab

8. Elranatamab

9. Ivosidenib”

Summary of 10 new indications/approvals in Heme Malignancies by FDA Oncology in 2023 - Oncology Brothers

Source: Oncology Brothers/X